No Data
No Data
Maintaining Hold: GoodRx's Steady Performance and Upcoming Investor Day Insights
GoodRx Holdings Inc (GDRX) Q1 2024 Earnings: Navigates Market Challenges With Strategic Adjustments
GoodRx Holdings First Quarter 2024 Earnings: US$0.003 Loss per Share (Vs US$0.008 Loss in 1Q 2023)
Solid Performance and Growth Potential Secure GoodRx a Buy Rating Despite Market Overreaction
GoodRx Holdings (GDRX) Gets a Buy From Barclays
GoodRx Holdings: Strong Q1 Performance and Upward Financial Guidance Justify Buy Rating